The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Commission on Cancer names Outstanding Achievement Award winners

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

THE COMMISSION ON CANCER of the American College of Surgeons granted its bi-annual Outstanding Achievement Award to 20 accredited cancer programs throughout the U.S. The awards were based on surveys conducted during the first half of the year.

The full list of award-winning cancer programs is available here.

The 20 award-winning programs represent approximately 9 percent of programs surveyed.

Table of Contents

YOU MAY BE INTERESTED IN

ClinicalRegulatory NewsTrials & Tribulations

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL). 
By Edison T. Liu
Sponsored

Why both somatic and germline genomic profiling are essential for precision oncology

Over the past three decades, cancer genetics has transformed precision oncology. Germline testing has advanced from single-gene Sanger sequencing to parallel sequencing of hundreds of genes, while tumor (somatic) testing has expanded with the rise of targeted therapies based on point mutations, copy number changes and other alterations. 
By Heather Hampel and David W. Craig
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account